Section Arrow
Quote
AXGN.NASDAQ
- Axogen
Quotes are at least 15-min delayed:2026/06/21 05:45 EDT
Regular Hours
Last
 44.84
+0.27 (+0.61%)
Day High 
45.83 
Prev. Close
44.57 
1-M High
45.68 
Volume 
1.30M 
Bid
44.45
Ask
45.5
Day Low
43.85 
Open
45.5 
1-M Low
38.075 
Market Cap 
2.37B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 42.79 
20-SMA 41.64 
50-SMA 40.21 
52-W High 45.83 
52-W Low 9.345 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.64/0.67
Enterprise Value
2.44B
Balance Sheet
Book Value Per Share
4.60
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
225.21M
Operating Revenue Per Share
2.86
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BFLYButterfly Network8.9+3.19+55.87%-- 
ABTAbbott Laboratories88.41-0.09-0.10%24.76PE
TNONTenon Medical Inc0.35-0.2521-41.87%-- 
BSXBoston Scientific Corp45.29+0.34+0.76%18.95PE
MDTMedtronic plc79.34+1.2+1.54%22.16PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health careproviders. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.